SCHEMBL14200344

SCHEMBL14200344

CC(C)c1ccc(N(C)C)c(N(C)C)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.41
TRPA1 O75762 1/20 0.40
PTGS1 P23219 1/20 0.40
CACNA1C Q13936 1/20 0.40
GAA P10253 2/20 0.39
ALDH1A1 P00352 1/20 0.39
ALOX12 P18054 1/20 0.39
HTT P42858 1/20 0.39
HIF1A Q16665 1/20 0.39
RNASEH1 O60930 1/20 0.36
TYR P14679 2/20 0.35
CRHR1 P34998 3/20 0.35
KIF11 P52732 1/20 0.34
HTR1D P28221 1/20 0.34
HTR1B P28222 1/20 0.34
HSP90AA1 P07900 1/20 0.33
HSP90AB1 P08238 1/20 0.33
KMT2A Q03164 1/20 0.33
MAPT P10636 1/20 0.33
NPC1 O15118 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19726444 0.87 TRPA1 (0.39) LMNATRPA1PTGS1CACNA1CGAA
SCHEMBL22193475 0.87 TRPA1 (0.39) LMNATRPA1PTGS1CACNA1CGAA
SCHEMBL7537241 0.82 LMNA (0.39) LMNATRPA1PTGS1CACNA1CGAA
SCHEMBL12248233 0.82 LMNA (0.39) LMNATRPA1PTGS1CACNA1CGAA
SCHEMBL14228579 0.82 LMNA (0.54) LMNATRPA1PTGS1CACNA1CGAA
SCHEMBL14328458 0.82 LMNA (0.48) LMNATRPA1PTGS1CACNA1CGAA
SCHEMBL22537759 0.80 LMNA (0.38) LMNATRPA1PTGS1CACNA1CGAA
SCHEMBL13320854 0.80 TRPA1 (0.55) LMNATRPA1PTGS1CACNA1CGAA
SCHEMBL12015793 0.80 PTGS2 (0.39) LMNATRPA1PTGS1CACNA1CGAA
SCHEMBL17813143 0.80 MAPT (0.50) CRHR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8778874-B2 Glycopeptide antibiotic monomer derivatives NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) 2014-07-15 US disclosed
US-20080097078-A1 Antibacterial activity against vancomycin-resistant bacteria SHIONOGI & CO., LTD. (JP) 2008-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080097078-A1 Antibacterial activity against vancomycin-resistant bacteria CSGALNACT1, MON2, NR2C2 LMNA 4466/4885TRPA1 4040/4885PTGS1 4716/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.